TrialBMJ open2025

Beliefs about medicines in relation to the initiation of cardiovascular preventive medications during a 3 year follow-up period after inclusion in the VIPVIZA trial: a cohort study.

Eva Sönnerstam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.